On 26 March 2025, Professor Langley and colleagues led a landmark initiative by bringing the Man Van to the House of Commons, offering on-site prostate cancer testing to Members of Parliament and parliamentary staff.
Throughout the day, the mobile clinic tested over 45 MPs, including the Speaker of the House, as well as 24 security personnel. The event was designed to raise awareness of prostate cancer and demonstrate the importance of accessible, early screening—particularly for men at higher risk.
The visit marked a significant moment in the Man Van’s ongoing mission to deliver community-based health interventions. By engaging directly with policymakers and staff, the initiative highlighted the potential of mobile diagnostics to improve outcomes and reduce barriers to care.
Professor Langley’s involvement reflects his continued commitment to advancing prostate cancer detection and promoting equitable access to screening services across the UK.
A groundbreaking new clinical trial—the LDR BURST Study—is set to begin recruitment. Led by Dr Carla Perna and Dr William Hayhurst, the trial will compare two advanced radiotherapy techniques: Low Dose Rate (LDR) Brachytherapy and Stereotactic Body Radiotherapy (SBRT).
Professor Stephen Langley of Royal Surrey Cancer Centre, alongside Professor Frank Chinegwundoh of St George’s University of London, have written a letter to the editor of The Times in response to the article “Screening every man for prostate cancer isn’t as helpful as it sounds.”
The University of Surrey has conferred an Honorary Doctorate upon Professor Langley, in recognition of his pioneering contributions to prostate cancer detection and treatment, and his leadership in advancing research and care across Surrey and beyond.
Professor Langley was honoured to speak at the All-Party Parliamentary Group (APPG) on Prostate Cancer at the House of Commons this week, joining fellow clinicians, researchers, and policymakers to discuss the future of prostate cancer diagnostics and care across the UK.
The treatment selector table will help you to discuss with your partner and your healthcare team if you are suitable for prostate brachytherapy.
Prostate brachytherapy is the only minimally invasive surgical treatment option recommended by NICE
Latest data from The Prostate Brachytherapy Centre shows
The Prostate Cancer Charity is aiming to put prostate cancer on the top of everyone’s agenda to show it really does matter.
The Prostate Brachytherapy Advisory Group has released a video entitled Prostate Brachytherapy….because relationships matter’ to highlight the impact that treatment choice may have on relationships.